- Home
- SRM vs ADXN Comparison
SRM vs ADXN Comparison
Compare SRM & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- ADXN
- Stock Information
- Founded
- SRM 1979
- ADXN 2002
- Country
- SRM United States
- ADXN Switzerland
- Employees
- SRM N/A
- ADXN N/A
- Industry
- SRM
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- ADXN Health Care
- Exchange
- SRM Nasdaq
- ADXN Nasdaq
- Market Cap
- SRM 9.0M
- ADXN 7.5M
- IPO Year
- SRM 2023
- ADXN N/A
- Fundamental
- Price
- SRM $0.43
- ADXN $7.60
- Analyst Decision
- SRM
- ADXN Strong Buy
- Analyst Count
- SRM 0
- ADXN 1
- Target Price
- SRM N/A
- ADXN $30.00
- AVG Volume (30 Days)
- SRM 278.8K
- ADXN 8.7K
- Earning Date
- SRM 05-09-2025
- ADXN 06-05-2025
- Dividend Yield
- SRM N/A
- ADXN N/A
- EPS Growth
- SRM N/A
- ADXN N/A
- EPS
- SRM N/A
- ADXN 0.06
- Revenue
- SRM $4,311,382.00
- ADXN $701,260.00
- Revenue This Year
- SRM N/A
- ADXN N/A
- Revenue Next Year
- SRM N/A
- ADXN N/A
- P/E Ratio
- SRM N/A
- ADXN $0.99
- Revenue Growth
- SRM N/A
- ADXN N/A
- 52 Week Low
- SRM $0.26
- ADXN $6.51
- 52 Week High
- SRM $1.66
- ADXN $17.05
- Technical
- Relative Strength Index (RSI)
- SRM 61.26
- ADXN 52.85
- Support Level
- SRM $0.28
- ADXN $6.75
- Resistance Level
- SRM $0.38
- ADXN $8.20
- Average True Range (ATR)
- SRM 0.06
- ADXN 0.46
- MACD
- SRM 0.01
- ADXN 0.06
- Stochastic Oscillator
- SRM 76.45
- ADXN 64.50
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.